Teva Director Hurvitz Supports Deals, Says Cost Cuts Necessary

Teva Pharmaceutical Industries Ltd. may be prepared to speed up the pace of acquisitions next year as Chief Executive Officer Jeremy Levin cuts costs and sets up a new management team, board member Chaim Hurvitz said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.